Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Editorial [Hot topic: Hepatocyte Growth Factor and cMET, New Development in Cancer Therapies (Guest Editors: T.A. Martin and W.G. Jiang)]
pp. 1-1(1)
Authors: Martin, T. A.; Jiang, W. G.

Hepatocyte Growth Factor and Its Receptor Signalling Complex as Targets in Cancer Therapy
pp. 2-6(5)
Authors: Martin, Tracey A.; Jiang, Wen G.

Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
pp. 7-27(21)
Authors: Underiner, Ted L.; Herbertz, Torsten; Miknyoczki, Sheila J.

An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
pp. 28-35(8)
Authors: Guessous, Fadila; Zhang, Ying; diPierro, Charles; Marcinkiewicz, Lukasz; Sarkaria, Jann; Schiff, David; Buchanan, Sean; Abounader, Roger

Anti-Cancer Approach with NK4: Bivalent Action and Mechanisms
pp. 36-46(11)
Authors: Nakamura, Takahiro; Sakai, Katsuya; Nakamura, Toshikazu; Matsumoto, Kunio

Hepatocyte Growth Factor Activation Inhibitors – Therapeutic Potential in Cancer
pp. 47-57(11)
Authors: Parr, Christian; Sanders, Andrew J.; Jiang, Wen G.

Application of Biological Study for Met Expression to Cancer Therapy
pp. 58-63(6)
Authors: Osada, Shinji; Yoshida, Kazuhiro

The Type II Transmembrane Serine Protease, Matriptase-2: Possible Links to Cancer?
pp. 64-69(6)
Authors: Sanders, Andrew J.; Webb, Siobhan L.; Parr, Christian; Mason, Malcolm D.; Jiang, Wen G.

Barminomycin, a Model for the Development of New Anthracyclines
pp. 70-77(8)
Authors: Kimura, K.; Spencer, D. M.S.; Bilardi, R.; Swift, L. P.; Box, A. J.; Brownlee, R. T.C.; Cutts, S. M.; Phillips, D. R.

Anticancer Activities and Mechanisms of Bisdioxopiperazine Compounds Probimane and MST-16
pp. 78-91(14)
Authors: Lu, Da-Yong; Lu, Ting-Ren

Male Fertility-Implications of Anticancer Treatment and Strategies to Mitigate Gonadotoxicity
pp. 92-102(11)
Authors: Ragheb, Ahmed M.; Sabanegh Jr., Edmund S.